PMID- 30916574 OWN - NLM STAT- MEDLINE DCOM- 20200206 LR - 20231213 IS - 1557-8852 (Electronic) IS - 1084-9785 (Linking) VI - 34 IP - 6 DP - 2019 Aug TI - Pyrroline-5-Carboxylate Reductase 1 Accelerates the Migration and Invasion of Nonsmall Cell Lung Cancer In Vitro. PG - 380-387 LID - 10.1089/cbr.2019.2782 [doi] AB - Background: Pyrroline-5-carboxylate reductase 1 (PYCR1) is involved in tumor progression, for instance, breast cancer and prostate cancer. However, its role in tumor metastasis, especially in nonsmall cell lung cancer (NSCLC), is still elusive. Materials and Methods: The messenger RNA (mRNA) expression of PYCR1 between NSCLC and normal lung specimens was compared using Oncomine database. The endogenous PYCR1 expressions in NSCLC cell lines 95C and H1299 were knocked down by lentiviral-mediated delivery of short hairpin RNA (shRNA). Then the effects of PYCR1 on the migration and invasion of NSCLC cells were studied by wound healing assay and transwell assay. Results: PYCR1 mRNA expression was significantly higher in NSCLC specimens than that in normal lung tissues. Depletion of PYCR1 in NSCLC cell significantly repressed the cell migration and invasion. Moreover, depletion of PYCR1 influenced the expression of epithelial-mesenchymal transition molecules E-cadherin, Vimentin, N-cadherin, and Snail1. Conclusions: Our data suggested that PYCR1 plays a positive role in NSCLC metastasis in vitro and might be a promising target for treating NSCLC. FAU - Sang, Senhua AU - Sang S AD - 1College of Life Science and Technology, Guangxi University, Nanning, China. AD - 2Shanghai Linger Biotechnology Co., Ltd., Shanghai, China. FAU - Zhang, Cuicui AU - Zhang C AD - 1College of Life Science and Technology, Guangxi University, Nanning, China. FAU - Shan, Jianwei AU - Shan J AD - 1College of Life Science and Technology, Guangxi University, Nanning, China. AD - 3Crops Research Institute, Guangdong Academy of Agricultural Sciences, Guangzhou, China. AD - 4Guangdong Provincial Key Laboratory of Crop Genetic Improvement, Guangzhou, China. LA - eng PT - Journal Article DEP - 20190327 PL - United States TA - Cancer Biother Radiopharm JT - Cancer biotherapy & radiopharmaceuticals JID - 9605408 RN - EC 1.5.1.- (Pyrroline Carboxylate Reductases) SB - IM MH - Apoptosis MH - Carcinoma, Non-Small-Cell Lung/genetics/metabolism/*pathology MH - *Cell Movement MH - Cell Proliferation MH - *Epithelial-Mesenchymal Transition MH - Humans MH - In Vitro Techniques MH - Lung Neoplasms/genetics/metabolism/*pathology MH - Neoplasm Invasiveness MH - Pyrroline Carboxylate Reductases/genetics/*metabolism MH - Tumor Cells, Cultured MH - delta-1-Pyrroline-5-Carboxylate Reductase OTO - NOTNLM OT - PYCR1 OT - invasion OT - migration OT - nonsmall cell lung cancer OT - shRNA EDAT- 2019/03/28 06:00 MHDA- 2020/02/07 06:00 CRDT- 2019/03/28 06:00 PHST- 2019/03/28 06:00 [pubmed] PHST- 2020/02/07 06:00 [medline] PHST- 2019/03/28 06:00 [entrez] AID - 10.1089/cbr.2019.2782 [doi] PST - ppublish SO - Cancer Biother Radiopharm. 2019 Aug;34(6):380-387. doi: 10.1089/cbr.2019.2782. Epub 2019 Mar 27.